CD49d blockade by natalizumab in patients with multiple sclerosis affects steady-state hematopoiesis and mobilizes progenitors with a distinct phenotype and function. (Q43185076)
Jump to navigation
Jump to search
scientific article published on 25 January 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CD49d blockade by natalizumab in patients with multiple sclerosis affects steady-state hematopoiesis and mobilizes progenitors with a distinct phenotype and function. |
scientific article published on 25 January 2010 |
Statements
CD49d blockade by natalizumab in patients with multiple sclerosis affects steady-state hematopoiesis and mobilizes progenitors with a distinct phenotype and function (English)
G Ehninger
U Oelschlaegel
R Ordemann
K Hölig
25 January 2010
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference